Constitution of Consultancy Committee of Key Stakeholders for Advice on Suo-Motu Disclosure under Section 4 of the RTI Act, 2005 in CDSCO

CDSCO (India)

NOTICE

Published: 6/16/2026Detected: 6/17/2026

Summary preview

Constitutes a consultancy committee of key stakeholders to advise CDSCO on how Suo-Motu disclosures under Section 4 of the RTI Act, 2005 should be handled in a regulatory context.

Get the full analysis, free

Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.

Create free account

#RTI Act 2005

#Suo-Motu disclosure

#CDSCO

#key stakeholders

#transparency

Official Source Document
Source Verified

Access the original document directly from INDIA CDSCO.

View Official Document

Get CDSCO (India) alerts in your inbox as they are published.

Free plan, 2-minute setup, no credit card required.

RegulatoryAlerts

Automated regulatory intelligence monitoring for pharmaceutical and biotech professionals. Track FDA, EMA, and Health Canada updates seamlessly.

Product

Insights
Updates by Therapeutic Area
FDA Updates
EMA Updates
Pricing
Features
Request Demo

Resources

Integration Guides
Regulatory Glossary
EMA Timeline
Best Practices
Therapeutic Areas

Company

About Us
Blog
Contact

Security

Not affiliated with the FDA, EMA, or Health Canada.

Summary preview

Get the full analysis, free

Official Source Document Source Verified

More from CDSCO (India)

Get CDSCO (India) alerts in your inbox as they are published.

Official Source Document
Source Verified